Marleny Novaes Figueiredo

Marleny Novaes Figueiredo

Auto-generated profile, based on publicly available information

Marleny Novaes Figueiredo

Division of HPB Surgery, Department of Surgery, Carolinas Medical Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2016 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
DMD. Mège
D. Mège
MFM. N. Figueiredo
M. N. Figueiredo
GMG. Manceau
G. Manceau
LML. Maggiori
L. Maggiori
YBY. Bouhnik
Y. Bouhnik
YPY. Panis
Y. Panis
There are very few studies and no consensus concerning the choice between two- and three-stage ileal pouch-anal anastomosis [IPAA] in inflammatory bowel diseases [IBD]. This study aimed to compare operative results between both surgical procedures. Only patients who underwent a laparoscopic IPAA for IBD were included. They were divided into two groups: two-stage [IPAA and stoma closure] [Group A] and three-stage IPAA [subtotal colectomy, IPAA, stoma closure] [Group B]. From 2000 to 2015, 185 patients (107 men, median age of 42 [range, 15–78] years) were divided into Groups A [ n = 82] and B [ n = 103]. Patients in Group B were younger than in Group A (39 [15–78] vs 43 [16–74] years; p = 0.019), presented more frequently with Crohn’s disease [16% vs 5%; p < 0.04], and were more frequently operated in emergency for acute colitis [37% vs 1%; p < 0.0001]. Cumulative operative time and length of stay were significantly longer in Group B (580 [300–900] min, and 19 [13–60] days) than in Group A (290 [145–490] min and 10 [7–47] days; p < 0.0001). Cumulative postoperative morbidity, delay for stoma closure, and function were similar between the two groups. Long-term morbidity was similar between Group A [13%] and Group B [21%; p = 0.18]. Our study suggested that postoperative morbidity was similar between two- and three-stage laparoscopic IPAA. It suggested that the three-stage procedure is probably safer for high-risk patients [ie in acute colitis].

1 January 2014 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
MFMarleny N. Figueiredo
Marleny N. Figueiredo
LMLéon Maggiori
Léon Maggiori
SGSebastien Gaujoux
Sebastien Gaujoux
ACAnne Couvelard
Anne Couvelard
NGNathalie Guedj
Nathalie Guedj
YPYves Panis
Yves Panis

24 February 2016 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
AHAngelita Habr-Gama
Angelita Habr-Gama
RPRodrigo Oliva Perez
Rodrigo Oliva Perez
GJGuilherme P. São Julião
Guilherme P. São Julião
IPIgor Proscurshim
Igor Proscurshim
LFLaura M. Fernandez
Laura M. Fernandez
CBCarlos Buchpiguel
Carlos Buchpiguel
Neoadjuvant CRT may lead to significant tumor regression in patients with rectal cancer. Different CRT regimens with consolidation chemotherapy may lead to increased rates of complete tumor regression. The purpose of this study was to understand tumor metabolic activity following two different neoadjuvant CRT regimens using sequential PET/CT imaging in two different intervals following RT. Patients with cT2-4 N0-2 M0 rectal cancer treated by standard CRT (54Gy and 2 cycles of 5FU-based chemotherapy) or extended CRT (54Gy and 6 cycles of 5FU-based chemotherapy) underwent sequential PET/CT imaging at baseline, 6 weeks and 12 weeks from radiation completion. 99 patients undergoing standard CRT were compared to 12 patients undergoing CRT with consolidation chemotherapy. Patients treated with consolidation CRT had increased rates of complete clinical or pathological response (66 % vs. 23 %; p < 0.001). SUVmax variation between baseline and 6 weeks (88 % vs. 63 %; p < 0.001) and between baseline and 12 weeks (90 % vs. 57 %; p < 0.001) were significantly more pronounced among patients undergoing extended CRT with consolidation chemotherapy. An increase in SUVmax between 6 and 12 weeks was observed in 51 % of patients undergoing standard and 18 % of patients undergoing consolidation CRT (p = 0.04). Most of the reduction in tumor metabolism after neoadjuvant CRT occurs within the first 6 weeks from RT completion. In patients undergoing CRT with consolidation chemotherapy, tumors are less likely to regain metabolic activity between 6 and 12 weeks. Therefore, assessment of tumor response may be safely postponed to 12 weeks in patients undergoing extended CRT with consolidation chemotherapy. NCT00254683

1 January 2015 in World Journal of Gastrointestinal Surgery
Verified
Journal Article
Open access
FCFábio Guilherme Campos
Fábio Guilherme Campos
MFMarleny Novaes Figueiredo
Marleny Novaes Figueiredo
CMCarlos Augusto Real Martinez
Carlos Augusto Real Martinez
Colorectal cancer (CRC) is a major cause of morbidity and mortality around the world, and approximately 5% of them develop in a context of inherited mutations leading to some form of familial colon cancer syndromes. Recognition and characterization of these patients have contributed to elucidate the genetic basis of CRC. Polyposis Syndromes may be categorized by the predominant histological structure found within the polyps. The aim of the present paper is to review the most important clinical features of the Hamartomatous Polyposis Syndromes, a rare group of genetic disorders formed by the peutz-Jeghers syndrome, juvenil polyposis syndrome and PTEN Hamartoma Tumor Syndrome (Bannayan-Riley-Ruvalacaba and Cowden Syndromes). A literature search was performed in order to retrieve the most recent and important papers (articles, reviews, clinical cases and clinical guidelines) regarding the studied subject. We searched for terms such as "hamartomatous polyposis syndromes", "Peutz-Jeghers syndrome", "juvenile polyposis syndrome", "juvenile polyp", and "PTEN hamartoma tumour syndrome" (Cowden syndrome, Bananyan-Riley-Ruvalcaba). The present article reports the wide spectrum of disease severity and extraintestinal manifestations, with a special focus on their potential to develop colorectal and other neoplasia. In the literature, the reported colorectal cancer risk for Juvenile Polyposis, Peutz-Jeghers and PTEN Hamartoma Tumor Syndromes are 39%-68%, 39%-57% and 18%, respectively. A review regarding cancer surveillance recommendations is also presented.

2 July 2015 in Techniques in Coloproctology
Verified
Journal Article
Closed access
PDF file
MFM. N. Figueiredo
M. N. Figueiredo
DMD. Mège
D. Mège
LML. Maggiori
L. Maggiori
MFM. Ferron
M. Ferron
YPY. Panis
Y. Panis

1 January 2016 in World Journal of Gastrointestinal Surgery
Verified
Journal Article
Open access
MFMarleny Novaes Figueiredo
Marleny Novaes Figueiredo
FCFábio Guilherme Campos
Fábio Guilherme Campos
Doppler-guided hemorrhoidal dearterialization/transanal hemorrhoidal dearterialization: Technical evolution and outcomes after 20 years